Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.7%

160 terminated/withdrawn out of 1092 trials

Success Rate

79.1%

-7.5% vs industry average

Late-Stage Pipeline

10%

110 trials in Phase 3/4

Results Transparency

41%

250 of 605 completed trials have results

Key Signals

152 recruiting250 with results92 terminated68 withdrawn

Enrollment Performance

Analytics

N/A

399(46.1%)

Phase 1

223(25.8%)

Phase 2

113(13.0%)

Phase 4

72(8.3%)

Phase 3

38(4.4%)

Early Phase 1

21(2.4%)

866Total

N/A(399)

Phase 1(223)

Phase 2(113)

Phase 4(72)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1092)

Showing 20 of 1092 trials

NCT03437928Not ApplicableRecruiting

DBS for Depression

Role: lead

NCT05514002Phase 4Completed

Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 Years

Role: collaborator

NCT05915741Active Not Recruiting

Brain Recordings in Patients Undergoing Deep Brain Stimulation (DBS) for Severe Obsessive-Compulsive Disorder (OCD)

Role: lead

NCT07024758Not ApplicableActive Not Recruiting

Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD

Role: lead

NCT07218549Phase 1Not Yet Recruiting

Evaluation of the Safety and Effects of Psychoactive Substances in People With Past Opioid Use

Role: collaborator

NCT07517666Not ApplicableEnrolling By Invitation

Genetic Information for Families After Tumor Testing Study

Role: collaborator

NCT07730125Phase 1Not Yet Recruiting

Gene-edited T Regulatory Cells (CRG-150) for the Treatment of Relapsed/Refractory Malignancies

Role: collaborator

NCT07674628Not ApplicableRecruiting

SALUD-M: Acceptance Based Coping Skills for Hispanic/Latinx Military Patients With Type 2 Diabetes

Role: lead

NCT07729397Phase 1Not Yet Recruiting

Autologous IC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma (ANCILE-30)

Role: collaborator

NCT07719088Phase 1Not Yet Recruiting

Psilocybin Effects on Healthy Aging Biomarkers and Purpose in Life

Role: collaborator

NCT07723937Recruiting

GelPOINT® Path-Assisted Endoscopic Removal of Colon and Rectal Polyps: A Feasibility and Safety Study

Role: lead

NCT06596447Not ApplicableRecruiting

Neurophysiological Investigation of the Approach-avoidance Axis in OCD: Applications to Neuromodulation

Role: lead

NCT04199000Recruiting

Clinical and Basic Investigations Into Congenital Disorders of Glycosylation

Role: collaborator

NCT07211737Phase 1Recruiting

NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma

Role: lead

NCT05439655Not ApplicableActive Not Recruiting

Acute Recording of Stereotyped High-Frequency Oscillations

Role: collaborator

NCT06176690Phase 1Recruiting

Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas

Role: lead

NCT06928909Recruiting

Leukemia Adapted Protocol

Role: lead

NCT00840853Phase 1Active Not Recruiting

Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT

Role: lead

NCT04288726Phase 1Recruiting

Allogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive Lymphomas

Role: lead

NCT03774654Phase 1Active Not Recruiting

CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)

Role: lead